These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 26523712)

  • 1. Detection and Differentiation of Frontotemporal Dementia and Related Disorders From Alzheimer Disease Using the Montreal Cognitive Assessment.
    Coleman KK; Coleman BL; MacKinley JD; Pasternak SH; Finger EC
    Alzheimer Dis Assoc Disord; 2016; 30(3):258-63. PubMed ID: 26523712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between Montreal Cognitive Assessment Sub-Item Scores and Corresponding Cognitive Test Performance in Patients with Frontotemporal Dementia and Related Disorders.
    Coleman KK; Coleman BL; MacKinley JD; Pasternak SH; Finger EC
    Dement Geriatr Cogn Disord; 2017; 43(3-4):170-179. PubMed ID: 28199994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Montreal Cognitive Assessment (MoCA): validation study for frontotemporal dementia.
    Freitas S; Simões MR; Alves L; Duro D; Santana I
    J Geriatr Psychiatry Neurol; 2012 Sep; 25(3):146-54. PubMed ID: 22859702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TMEM106B Effect on cognition in Parkinson disease and frontotemporal dementia.
    Tropea TF; Mak J; Guo MH; Xie SX; Suh E; Rick J; Siderowf A; Weintraub D; Grossman M; Irwin D; Wolk DA; Trojanowski JQ; Van Deerlin V; Chen-Plotkin AS
    Ann Neurol; 2019 Jun; 85(6):801-811. PubMed ID: 30973966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Depressive Symptoms Negatively Impact Montreal Cognitive Assessment Performance: A Memory Clinic Experience.
    Blair M; Coleman K; Jesso S; Desbeaumes Jodoin V; Smolewska K; Warriner E; Finger E; Pasternak SH
    Can J Neurol Sci; 2016 Jul; 43(4):513-7. PubMed ID: 26842678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Montreal Cognitive Assessment: validity and utility in a memory clinic setting.
    Smith T; Gildeh N; Holmes C
    Can J Psychiatry; 2007 May; 52(5):329-32. PubMed ID: 17542384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Montreal Cognitive Assessment Memory Index Score (MoCA-MIS) as a predictor of conversion from mild cognitive impairment to Alzheimer's disease.
    Julayanont P; Brousseau M; Chertkow H; Phillips N; Nasreddine ZS
    J Am Geriatr Soc; 2014 Apr; 62(4):679-84. PubMed ID: 24635004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuropsychological Testing in Pathologically Verified Alzheimer Disease and Frontotemporal Dementia: How Well Do the Uniform Data Set Measures Differentiate Between Diseases?
    Ritter AR; Leger GC; Miller JB; Banks SJ
    Alzheimer Dis Assoc Disord; 2017; 31(3):187-191. PubMed ID: 28005562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [DEX and executive dysfunction in activities of daily living in Alzheimer's disease and frontotemporal dementia].
    Piquard A; Derouesné C; Meininger V; Lacomblez L
    Psychol Neuropsychiatr Vieil; 2010 Sep; 8(3):215-24; quiz 225-7. PubMed ID: 20739260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brief screening tool for mild cognitive impairment in older Japanese: validation of the Japanese version of the Montreal Cognitive Assessment.
    Fujiwara Y; Suzuki H; Yasunaga M; Sugiyama M; Ijuin M; Sakuma N; Inagaki H; Iwasa H; Ura C; Yatomi N; Ishii K; Tokumaru AM; Homma A; Nasreddine Z; Shinkai S
    Geriatr Gerontol Int; 2010 Jul; 10(3):225-32. PubMed ID: 20141536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overlap between frontotemporal dementia and Alzheimer's disease: cerebrospinal fluid pattern and neuroimaging study.
    Padovani A; Premi E; Pilotto A; Gazzina S; Cosseddu M; Archetti S; Cancelli V; Paghera B; Borroni B
    J Alzheimers Dis; 2013; 36(1):49-55. PubMed ID: 23568100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparisons of clinical symptoms in biomarker-confirmed Alzheimer's disease, dementia with Lewy bodies, and frontotemporal dementia patients in a local memory clinic.
    Shea YF; Ha J; Chu LW
    Psychogeriatrics; 2015 Dec; 15(4):235-41. PubMed ID: 25533477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validity of the Georgian Montreal Cognitive Assessment for the Screening of Mild Cognitive Impairment and Dementia.
    Janelidze M; Mikeladze N; Bochorishvili N; Dzagnidze A; Kapianidze M; Mikava N; Khatiashvili I; Kakhiani D; Mirvelashvili E; Shiukashvili N; Nadareishvili Z
    Am J Alzheimers Dis Other Demen; 2017 Feb; 32(1):36-40. PubMed ID: 27909150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validity and Reliability of the Frontotemporal Dementia Rating Scale (FTD-FRS) for the Progression and Staging of Dementia in Brazilian Patients.
    Lima-Silva TB; Bahia VS; Cecchini MA; Cassimiro L; Guimarães HC; Gambogi LB; Caramelli P; Balthazar M; Damasceno B; Brucki SMD; de Souza LC; Nitrini R; Mioshi E; Yassuda MS
    Alzheimer Dis Assoc Disord; 2018; 32(3):220-225. PubMed ID: 29438114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Luria's three-step test: what is it and what does it tell us?
    Weiner MF; Hynan LS; Rossetti H; Falkowski J
    Int Psychogeriatr; 2011 Dec; 23(10):1602-6. PubMed ID: 21554794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Apathy in frontotemporal dementia and Alzheimer's disease: are there distinct profiles?].
    Derouesné C; Lacomblez L; Fiori N; Gély-Nargeot MC; Bungener C
    Geriatr Psychol Neuropsychiatr Vieil; 2012 Mar; 10(1):107-15. PubMed ID: 22414405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Behavioral and affective features of amyotrophic lateral sclerosis patients.
    Ohta Y; Sato K; Takemoto M; Takahashi Y; Morihara R; Nakano Y; Tsunoda K; Nomura E; Hishikawa N; Yamashita T; Abe K
    J Neurol Sci; 2017 Oct; 381():119-125. PubMed ID: 28991661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of the Montreal Cognitive Assessment (MoCA) in Spanish as a screening tool for mild cognitive impairment and mild dementia in patients over 65 years old in Bogotá, Colombia.
    Gil L; Ruiz de Sánchez C; Gil F; Romero SJ; Pretelt Burgos F
    Int J Geriatr Psychiatry; 2015 Jun; 30(6):655-62. PubMed ID: 25320026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rate of progression differs in frontotemporal dementia and Alzheimer disease.
    Rascovsky K; Salmon DP; Lipton AM; Leverenz JB; DeCarli C; Jagust WJ; Clark CM; Mendez MF; Tang-Wai DF; Graff-Radford NR; Galasko D
    Neurology; 2005 Aug; 65(3):397-403. PubMed ID: 16087904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Italians do it worse. Montreal Cognitive Assessment (MoCA) optimal cut-off scores for people with probable Alzheimer's disease and with probable cognitive impairment.
    Bosco A; Spano G; Caffò AO; Lopez A; Grattagliano I; Saracino G; Pinto K; Hoogeveen F; Lancioni GE
    Aging Clin Exp Res; 2017 Dec; 29(6):1113-1120. PubMed ID: 28155182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.